BioSpace News Archive

HTG Molecular Diagnostics, Inc., a life science company whose mission is to advance precision medicine, announced three of its previously released Research Use Only assays are now available for use with the Thermo Fisher Scientific Ion Torrent Ion S5 next-generation sequencing platform.

- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that Ted Schroeder, Chief Executive Offer at Nabriva, will provide a company overview and business update at the 2020 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 12th, at 2:20p.m. ET. The presentation will be webcast live a

Bellicum Pharmaceuticals, Inc., a leader in developing novel, controllable cellular immunotherapies for cancers, announced it will report financial results for the second quarter 2020 after the close of U.S. markets on Thursday, August 6, 2020.

Virtual Presentation Highlights New ANJESO Clinical Results, Including Safety, Reductions in Opioid Use and Time to Bowel Function Recovery Data When Administered Preoperatively Prior to Colorectal Surgery

electroCore, Inc., a commercial-stage bioelectronic medicine company, announced more information about availability, distribution and pricing for gammaCore Sapphire™ CV non-invasive vagus nerve stimulation therapy under its Emergency Use Authorization.

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its second quarter of 2020 ended June 30, 2020, after the market closes on Thursday, August 6th, 2020, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time. To access the conference call, dial toll free (800) 708-4540, five minutes before the conference. The passcode for the conference call is 4984

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the Company plans to participate in the upcoming virtual Canaccord Genuity Annual Growth Conference. Management is scheduled to present Thursday, August 13, 2020 at 9:30am ET. Interested parties may access a live and recorded webcast of the presentation on the “Investors” section of the Company’s website at www.t2biosystems

Stryker (NYSE:SYK) reported operating results for the second quarter of 2020: The response to the COVID-19 pandemic has included unprecedented measures to slow the spread of the virus taken by local governments and health care authorities globally, including the postponement of deferrable medical procedures and social contact restrictions, which have had a significant negative impact on Stryker’s operations and financial results. Secon

REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today announced that it will host a conference call on Thursday, August 6, 2020, at 4:30 p.m. ET to discuss its financial results for the quarter ended June 30, 2020, and recent operational highlights.

Envista Holdings Corporation (NYSE: NVST) today announced results for the second quarter 2020.